L01EX03 - search results

votrient tablet

novartis pharmaceuticals canada inc - pazopanib (pazopanib hydrochloride) - tablet - 200mg - pazopanib (pazopanib hydrochloride) 200mg - antineoplastic agents

Canada - English - Health Canada

votrient tablet

novartis pharmaceuticals canada inc - pazopanib (pazopanib hydrochloride) - tablet - 400mg - pazopanib (pazopanib hydrochloride) 400mg - antineoplastic agents

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

votrient tablets film-coated

glaxo wellcome s.a. - pazopanib - tablets film-coated - 400mg

Malta - English - Medicines Authority

pazopanib lotus 200 mg film-coated tablets

lotus support services s.r.l. 47 theodor pallady blvd. 2nd office, entrance b, 1st floor 3rd district bucharest, romania - pazopanib - film-coated tablet - pazopanib 200 mg - antineoplastic agents

votrient tablets film-coated

glaxo wellcome s.a. - pazopanib - tablets film-coated - 400mg

votrient tablets film-coated

glaxo wellcome s.a. - pazopanib - tablets film-coated - 400mg

Canada - English - Health Canada

sandoz pazopanib tablet

sandoz canada incorporated - pazopanib (pazopanib hydrochloride) - tablet - 200mg - pazopanib (pazopanib hydrochloride) 200mg - antineoplastic agents

Malta - English - Medicines Authority

pazopanib pharos 200mg film-coated tablets

pharos – pharmaceutical oriented services limited lesvou str. (end), thesi loggos, industrial zone, 144 52 metamorfossi attikis,, greece - pazopanib - film-coated tablet - pazopanib 200 mg - antineoplastic agents

Malta - English - Medicines Authority

pazopanib pharos 400mg film-coated tablets

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pazopanib eg 200 mg film-coat. tabl.

eg sa-nv - pazopanib hydrochloride 216,7 mg - eq. pazopanib 200 mg - film-coated tablet - 200 mg - pazopanib hydrochloride 216.7 mg - pazopanib